

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | chondrocyte proliferation (GO:0035988) | 6.47602135 |
| 2 | protein heterotrimerization (GO:0070208) | 6.40205735 |
| 3 | * collagen fibril organization (GO:0030199) | 6.39856806 |
| 4 | skin morphogenesis (GO:0043589) | 5.34343925 |
| 5 | endodermal cell differentiation (GO:0035987) | 5.32973520 |
| 6 | sequestering of extracellular ligand from receptor (GO:0035581) | 5.31036101 |
| 7 | cell adhesion mediated by integrin (GO:0033627) | 5.10691213 |
| 8 | response to peptidoglycan (GO:0032494) | 5.08265896 |
| 9 | regulation of mononuclear cell migration (GO:0071675) | 5.06188021 |
| 10 | negative regulation of interleukin-12 production (GO:0032695) | 5.01019383 |
| 11 | regulation of vitamin D biosynthetic process (GO:0060556) | 4.89718175 |
| 12 | bone trabecula formation (GO:0060346) | 4.80920903 |
| 13 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 4.71671320 |
| 14 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 4.68444029 |
| 15 | glycosphingolipid catabolic process (GO:0046479) | 4.43182384 |
| 16 | negative regulation of fatty acid transport (GO:2000192) | 4.34676006 |
| 17 | cellular response to thyroid hormone stimulus (GO:0097067) | 4.21565680 |
| 18 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 4.16632487 |
| 19 | axon extension involved in axon guidance (GO:0048846) | 4.16632487 |
| 20 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 4.14924660 |
| 21 | collagen metabolic process (GO:0032963) | 4.13079784 |
| 22 | oligosaccharide catabolic process (GO:0009313) | 4.12209078 |
| 23 | negative regulation of chondrocyte differentiation (GO:0032331) | 4.08302588 |
| 24 | collagen catabolic process (GO:0030574) | 4.04518790 |
| 25 | mesenchymal-epithelial cell signaling (GO:0060638) | 4.01965354 |
| 26 | wound healing, spreading of epidermal cells (GO:0035313) | 4.00383276 |
| 27 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.98197582 |
| 28 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.95454314 |
| 29 | glycolipid catabolic process (GO:0019377) | 3.95177513 |
| 30 | multicellular organismal macromolecule metabolic process (GO:0044259) | 3.88167678 |
| 31 | regulation of vitamin metabolic process (GO:0030656) | 3.86585371 |
| 32 | regulation of podosome assembly (GO:0071801) | 3.81595534 |
| 33 | metanephric mesenchyme development (GO:0072075) | 3.81398095 |
| 34 | basement membrane organization (GO:0071711) | 3.80692105 |
| 35 | cellular response to vitamin (GO:0071295) | 3.78826519 |
| 36 | kidney mesenchyme development (GO:0072074) | 3.77947612 |
| 37 | extracellular matrix disassembly (GO:0022617) | 3.77003535 |
| 38 | macrophage activation involved in immune response (GO:0002281) | 3.74071285 |
| 39 | multicellular organismal catabolic process (GO:0044243) | 3.71444998 |
| 40 | protein localization to cell surface (GO:0034394) | 3.70898200 |
| 41 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 3.69980151 |
| 42 | multicellular organismal metabolic process (GO:0044236) | 3.66652405 |
| 43 | hippo signaling (GO:0035329) | 3.63307146 |
| 44 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 3.59429954 |
| 45 | wound healing, spreading of cells (GO:0044319) | 3.55885398 |
| 46 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 3.54152364 |
| 47 | dermatan sulfate biosynthetic process (GO:0030208) | 3.53170746 |
| 48 | neutrophil activation involved in immune response (GO:0002283) | 3.53080527 |
| 49 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger (GO:0007199 | 3.52765125 |
| 50 | T-helper 1 type immune response (GO:0042088) | 3.51331694 |
| 51 | peptidyl-proline hydroxylation (GO:0019511) | 3.50413628 |
| 52 | protein localization to endosome (GO:0036010) | 3.49649278 |
| 53 | ceramide catabolic process (GO:0046514) | 3.47527180 |
| 54 | craniofacial suture morphogenesis (GO:0097094) | 3.45809017 |
| 55 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 3.43008294 |
| 56 | endocardial cushion development (GO:0003197) | 3.42440104 |
| 57 | positive regulation of monocyte chemotaxis (GO:0090026) | 3.41616822 |
| 58 | detection of molecule of bacterial origin (GO:0032490) | 3.39360372 |
| 59 | regulation of chemokine biosynthetic process (GO:0045073) | 3.39315553 |
| 60 | apoptotic cell clearance (GO:0043277) | 3.37700389 |
| 61 | glomerular basement membrane development (GO:0032836) | 3.37630791 |
| 62 | cellular response to vitamin D (GO:0071305) | 3.37331550 |
| 63 | positive regulation of heat generation (GO:0031652) | 3.34087125 |
| 64 | germ cell migration (GO:0008354) | 3.34067766 |
| 65 | amino sugar catabolic process (GO:0046348) | 3.33614578 |
| 66 | regulation of cytokine secretion involved in immune response (GO:0002739) | 3.33387127 |
| 67 | plasma membrane repair (GO:0001778) | 3.32555974 |
| 68 | response to thyroid hormone (GO:0097066) | 3.32268355 |
| 69 | cellular response to interferon-alpha (GO:0035457) | 3.31573199 |
| 70 | extracellular matrix assembly (GO:0085029) | 3.31013356 |
| 71 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 3.30670922 |
| 72 | cell migration involved in sprouting angiogenesis (GO:0002042) | 3.30190578 |
| 73 | monocyte chemotaxis (GO:0002548) | 3.28116253 |
| 74 | regulation of macrophage chemotaxis (GO:0010758) | 3.27597277 |
| 75 | cartilage development involved in endochondral bone morphogenesis (GO:0060351) | 3.25853690 |
| 76 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.24088343 |
| 77 | negative regulation of cartilage development (GO:0061037) | 3.21260295 |
| 78 | hydrogen peroxide biosynthetic process (GO:0050665) | 3.18729251 |
| 79 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.18060725 |
| 80 | barbed-end actin filament capping (GO:0051016) | 3.17291081 |
| 81 | positive regulation by symbiont of host defense response (GO:0052509) | 3.15799910 |
| 82 | modulation by symbiont of host defense response (GO:0052031) | 3.15799910 |
| 83 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.15799910 |
| 84 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.15799910 |
| 85 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.15799910 |
| 86 | modulation by symbiont of host immune response (GO:0052553) | 3.15799910 |
| 87 | dermatan sulfate metabolic process (GO:0030205) | 3.14761858 |
| 88 | regulation of fever generation (GO:0031620) | 3.14557470 |
| 89 | regulation of tight junction assembly (GO:2000810) | 3.14402369 |
| 90 | positive regulation of epithelial to mesenchymal transition (GO:0010718) | 3.13192954 |
| 91 | embryonic cranial skeleton morphogenesis (GO:0048701) | 3.12949315 |
| 92 | * epoxygenase P450 pathway (GO:0019373) | 3.12097813 |
| 93 | substrate adhesion-dependent cell spreading (GO:0034446) | 3.10929013 |
| 94 | NIK/NF-kappaB signaling (GO:0038061) | 3.10724781 |
| 95 | chondrocyte development (GO:0002063) | 3.10516447 |
| 96 | eosinophil chemotaxis (GO:0048245) | 3.09942519 |
| 97 | positive regulation of leukocyte degranulation (GO:0043302) | 3.09000377 |
| 98 | vascular endothelial growth factor signaling pathway (GO:0038084) | 3.07441778 |
| 99 | regulation of monocyte chemotaxis (GO:0090025) | 3.06379298 |
| 100 | stress fiber assembly (GO:0043149) | 3.05840507 |
| 101 | mesodermal cell differentiation (GO:0048333) | 3.05796153 |
| 102 | protein hydroxylation (GO:0018126) | 3.05495345 |
| 103 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.05420423 |
| 104 | negative regulation of focal adhesion assembly (GO:0051895) | 3.04480405 |
| 105 | negative regulation of cell junction assembly (GO:1901889) | 3.04480405 |
| 106 | negative regulation of adherens junction organization (GO:1903392) | 3.04480405 |
| 107 | keratan sulfate catabolic process (GO:0042340) | 3.02943690 |
| 108 | adhesion of symbiont to host cell (GO:0044650) | 3.02422492 |
| 109 | virion attachment to host cell (GO:0019062) | 3.02422492 |
| 110 | negative regulation of catenin import into nucleus (GO:0035414) | 3.00087629 |
| 111 | * extracellular matrix organization (GO:0030198) | 2.99551182 |
| 112 | positive regulation of fibroblast migration (GO:0010763) | 2.98842388 |
| 113 | regulation of interferon-alpha production (GO:0032647) | 2.98754761 |
| 114 | * extracellular structure organization (GO:0043062) | 2.98251352 |
| 115 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 2.95646745 |
| 116 | immunoglobulin mediated immune response (GO:0016064) | 2.93276365 |
| 117 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.92601515 |
| 118 | endothelial cell morphogenesis (GO:0001886) | 2.91928979 |
| 119 | decidualization (GO:0046697) | 2.91666867 |
| 120 | myeloid dendritic cell differentiation (GO:0043011) | 2.91186607 |
| 121 | sphingolipid catabolic process (GO:0030149) | 2.89081092 |
| 122 | negative regulation of embryonic development (GO:0045992) | 2.88376618 |
| 123 | regulation of branching involved in salivary gland morphogenesis (GO:0060693) | 2.87372371 |
| 124 | extracellular negative regulation of signal transduction (GO:1900116) | 2.87290281 |
| 125 | extracellular regulation of signal transduction (GO:1900115) | 2.87290281 |
| 126 | positive regulation of osteoblast proliferation (GO:0033690) | 2.86955942 |
| 127 | cellular response to lipopolysaccharide (GO:0071222) | 2.86838717 |
| 128 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 2.86457617 |
| 129 | regulation of toll-like receptor 4 signaling pathway (GO:0034143) | 2.86362688 |
| 130 | regulation of cholesterol storage (GO:0010885) | 2.86213376 |
| 131 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.85037170 |
| 132 | germinal center formation (GO:0002467) | 2.83765564 |
| 133 | outer ear morphogenesis (GO:0042473) | 2.83160690 |
| 134 | regulation of establishment of planar polarity involved in neural tube closure (GO:0090178) | 2.83096367 |
| 135 | cranial suture morphogenesis (GO:0060363) | 2.82878449 |
| 136 | * epithelial cell-cell adhesion (GO:0090136) | 2.82672817 |
| 137 | positive regulation of mesenchymal cell proliferation (GO:0002053) | 2.82423292 |
| 138 | regulation of mast cell degranulation (GO:0043304) | 2.81649289 |
| 139 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.80470180 |
| 140 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.80461116 |
| 141 | regulation of nitric oxide biosynthetic process (GO:0045428) | 2.80126419 |
| 142 | middle ear morphogenesis (GO:0042474) | 2.79375511 |
| 143 | negative regulation of lipid storage (GO:0010888) | 2.79159602 |
| 144 | regulation of cartilage development (GO:0061035) | 2.78399729 |
| 145 | regulation of SMAD protein import into nucleus (GO:0060390) | 2.78115474 |
| 146 | granulocyte activation (GO:0036230) | 2.77715794 |
| 147 | cellular response to molecule of bacterial origin (GO:0071219) | 2.77231864 |
| 148 | eosinophil migration (GO:0072677) | 2.76984734 |
| 149 | response to laminar fluid shear stress (GO:0034616) | 2.76299882 |
| 150 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.75957247 |
| 151 | N-acetylneuraminate metabolic process (GO:0006054) | 2.75877625 |
| 152 | cellular response to arsenic-containing substance (GO:0071243) | 2.74321155 |
| 153 | reactive oxygen species biosynthetic process (GO:1903409) | 2.74065990 |
| 154 | positive regulation of interleukin-6 production (GO:0032755) | 2.73774482 |
| 155 | cellular response to amino acid stimulus (GO:0071230) | 2.72828085 |
| 156 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.72458432 |
| 157 | substrate-dependent cell migration (GO:0006929) | 2.71514156 |
| 158 | * membrane lipid catabolic process (GO:0046466) | 2.71273840 |
| 159 | regulation of leukocyte degranulation (GO:0043300) | 2.70765657 |
| 160 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 2.70708069 |
| 161 | regulation of chondrocyte differentiation (GO:0032330) | 2.70673335 |
| 162 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.70239580 |
| 163 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition | 2.70000425 |
| 164 | eye morphogenesis (GO:0048592) | 2.69307706 |
| 165 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.68455152 |
| 166 | positive regulation of macrophage activation (GO:0043032) | 2.68335863 |
| 167 | cell-substrate junction assembly (GO:0007044) | 2.68195436 |
| 168 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.67930330 |
| 169 | regulation of gastrulation (GO:0010470) | 2.67805407 |
| 170 | regulation of chronic inflammatory response (GO:0002676) | 2.67462499 |
| 171 | COPI coating of Golgi vesicle (GO:0048205) | 2.65517433 |
| 172 | Golgi transport vesicle coating (GO:0048200) | 2.65517433 |
| 173 | response to muramyl dipeptide (GO:0032495) | 2.64992457 |
| 174 | cell-matrix adhesion (GO:0007160) | 2.63764953 |
| 175 | negative chemotaxis (GO:0050919) | 2.63353453 |
| 176 | negative regulation of smooth muscle cell migration (GO:0014912) | 2.62329025 |
| 177 | smooth muscle tissue development (GO:0048745) | 2.62237345 |
| 178 | extracellular fibril organization (GO:0043206) | 2.62091593 |
| 179 | adherens junction assembly (GO:0034333) | 2.61928305 |
| 180 | positive regulation of nitric oxide biosynthetic process (GO:0045429) | 2.61761102 |
| 181 | cellular extravasation (GO:0045123) | 2.61596698 |
| 182 | blood vessel endothelial cell migration (GO:0043534) | 2.60799756 |
| 183 | positive regulation of interferon-alpha production (GO:0032727) | 2.60619228 |
| 184 | response to fluid shear stress (GO:0034405) | 2.60594706 |
| 185 | pinocytosis (GO:0006907) | 2.60421122 |
| 186 | adhesion of symbiont to host (GO:0044406) | 2.59183581 |
| 187 | vitamin D metabolic process (GO:0042359) | 2.58821258 |
| 188 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.57646903 |
| 189 | regulation of early endosome to late endosome transport (GO:2000641) | 2.57539320 |
| 190 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.56971076 |
| 191 | iron ion import (GO:0097286) | 2.56442820 |
| 192 | macrophage activation (GO:0042116) | 2.55176165 |
| 193 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.54278454 |
| 194 | positive regulation of type 2 immune response (GO:0002830) | 2.54167644 |
| 195 | detection of external biotic stimulus (GO:0098581) | 2.53997598 |
| 196 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 2.53796436 |
| 197 | positive regulation of mast cell activation (GO:0033005) | 2.53043274 |
| 198 | type I interferon signaling pathway (GO:0060337) | 2.52996671 |
| 199 | cellular response to type I interferon (GO:0071357) | 2.52996671 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 6.58131771 |
| 2 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 5.89612345 |
| 3 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 4.73841474 |
| 4 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.34075262 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.15984920 |
| 6 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 3.92835370 |
| 7 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.65451015 |
| 8 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.51144617 |
| 9 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.47083072 |
| 10 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.38269987 |
| 11 | CLOCK_20551151_ChIP-Seq_293T_Human | 3.37657318 |
| 12 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.35933440 |
| 13 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 3.27396799 |
| 14 | * TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 3.22105299 |
| 15 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.07775510 |
| 16 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.96867425 |
| 17 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 2.90908743 |
| 18 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 2.63837250 |
| 19 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 2.62461633 |
| 20 | * CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 2.60303402 |
| 21 | CJUN_26792858_Chip-Seq_BT549_Human | 2.57658547 |
| 22 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 2.49767904 |
| 23 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 2.34392315 |
| 24 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.33413439 |
| 25 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.32058136 |
| 26 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.31990674 |
| 27 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.21547375 |
| 28 | * BRD4_25478319_ChIP-Seq_HGPS_Human | 2.20428646 |
| 29 | * NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 2.17861987 |
| 30 | * NRF2_20460467_ChIP-Seq_MEFs_Mouse | 2.17861987 |
| 31 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.16134468 |
| 32 | VDR_24787735_ChIP-Seq_THP-1_Human | 2.14693195 |
| 33 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 2.11423988 |
| 34 | * WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 2.10149442 |
| 35 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.05835113 |
| 36 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 2.01675387 |
| 37 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.98104648 |
| 38 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.92815803 |
| 39 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.89475387 |
| 40 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.88407065 |
| 41 | * PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.85703671 |
| 42 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.83104287 |
| 43 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.82995231 |
| 44 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.82464810 |
| 45 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.82464810 |
| 46 | SPI1_23127762_ChIP-Seq_K562_Human | 1.81323202 |
| 47 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.79598831 |
| 48 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.73081262 |
| 49 | * HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.71592406 |
| 50 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.71026962 |
| 51 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.64096042 |
| 52 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.63815222 |
| 53 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.63811107 |
| 54 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.62630520 |
| 55 | TP53_16413492_ChIP-PET_HCT116_Human | 1.62458663 |
| 56 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.61635612 |
| 57 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.60833003 |
| 58 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.59974753 |
| 59 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.59893472 |
| 60 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.56255555 |
| 61 | * ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.54946414 |
| 62 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.54898641 |
| 63 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.54794956 |
| 64 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.54717525 |
| 65 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.54184702 |
| 66 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.54012523 |
| 67 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.53245815 |
| 68 | * ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.51820200 |
| 69 | * TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.51379905 |
| 70 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.48801995 |
| 71 | * SOX2_20726797_ChIP-Seq_SW620_Human | 1.47517627 |
| 72 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.47511397 |
| 73 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.47296587 |
| 74 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.46097475 |
| 75 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.45969503 |
| 76 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.45125321 |
| 77 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.43890220 |
| 78 | * PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.41893218 |
| 79 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.39289052 |
| 80 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.38984148 |
| 81 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.38451056 |
| 82 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.36657963 |
| 83 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.36612796 |
| 84 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.36468245 |
| 85 | ATF3_27146783_Chip-Seq_COLON_Human | 1.34955572 |
| 86 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.33705303 |
| 87 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.33694636 |
| 88 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.33609881 |
| 89 | * NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.33157578 |
| 90 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.33058370 |
| 91 | GATA1_22025678_ChIP-Seq_K562_Human | 1.30532364 |
| 92 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.28144471 |
| 93 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.27565195 |
| 94 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.23779189 |
| 95 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.20565362 |
| 96 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.19720314 |
| 97 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 1.18736471 |
| 98 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.17086765 |
| 99 | * ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.16676127 |
| 100 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.16075446 |
| 101 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.16015033 |
| 102 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.15948067 |
| 103 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.15889756 |
| 104 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.14525578 |
| 105 | * EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.13418453 |
| 106 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.13048679 |
| 107 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.12342653 |
| 108 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.12342653 |
| 109 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.11308996 |
| 110 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.10757919 |
| 111 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.10259320 |
| 112 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.10150628 |
| 113 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.10104184 |
| 114 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.09446326 |
| 115 | * RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.08424146 |
| 116 | * EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.08424146 |
| 117 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.06573126 |
| 118 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.06289837 |
| 119 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.06009921 |
| 120 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.05809805 |
| 121 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.05501512 |
| 122 | * KLF5_25053715_ChIP-Seq_YYC3_Human | 1.04929821 |
| 123 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.04730459 |
| 124 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.04689873 |
| 125 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.04665526 |
| 126 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.03494202 |
| 127 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.03251697 |
| 128 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.03211794 |
| 129 | MAF_26560356_Chip-Seq_TH1_Human | 1.02659888 |
| 130 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.02290678 |
| 131 | * UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.02197859 |
| 132 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.01978227 |
| 133 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.01646139 |
| 134 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.01321351 |
| 135 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.00884347 |
| 136 | GATA1_19941826_ChIP-Seq_K562_Human | 1.00481671 |
| 137 | RXR_22108803_ChIP-Seq_LS180_Human | 0.99329475 |
| 138 | SA1_22415368_ChIP-Seq_MEFs_Mouse | 0.98410812 |
| 139 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.98389220 |
| 140 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.97670511 |
| 141 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.96044974 |
| 142 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 0.95531340 |
| 143 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.95173755 |
| 144 | KDM2B_26808549_Chip-Seq_K562_Human | 0.95030514 |
| 145 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.94973478 |
| 146 | * PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.94579120 |
| 147 | * SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.94353263 |
| 148 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.94234091 |
| 149 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.94007981 |
| 150 | * RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.93840590 |
| 151 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.92993174 |
| 152 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.92713679 |
| 153 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.92124677 |
| 154 | * PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.92088788 |
| 155 | * TP63_23658742_ChIP-Seq_EP156T_Human | 0.91535735 |
| 156 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 0.91102493 |
| 157 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.91083399 |
| 158 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.90852655 |
| 159 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.89787647 |
| 160 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.88955506 |
| 161 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.88620105 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0008438_abnormal_cutaneous_collagen | 8.03098459 |
| 2 | MP0005275_abnormal_skin_tensile | 5.25705112 |
| 3 | MP0003705_abnormal_hypodermis_morpholog | 4.75532026 |
| 4 | MP0005503_abnormal_tendon_morphology | 4.56164613 |
| 5 | MP0005058_abnormal_lysosome_morphology | 4.18465022 |
| 6 | MP0003303_peritoneal_inflammation | 3.98917267 |
| 7 | MP0003279_aneurysm | 3.87536203 |
| 8 | MP0001958_emphysema | 3.33366406 |
| 9 | MP0006082_CNS_inflammation | 3.19603344 |
| 10 | MP0009384_cardiac_valve_regurgitation | 3.12246324 |
| 11 | MP0005623_abnormal_meninges_morphology | 3.07003450 |
| 12 | MP0009840_abnormal_foam_cell | 3.05779987 |
| 13 | MP0002148_abnormal_hypersensitivity_rea | 2.94589912 |
| 14 | MP0003436_decreased_susceptibility_to | 2.84268430 |
| 15 | MP0004272_abnormal_basement_membrane | 2.69232494 |
| 16 | MP0010352_gastrointestinal_tract_polyps | 2.55832860 |
| 17 | MP0009785_altered_susceptibility_to | 2.54585213 |
| 18 | MP0000343_altered_response_to | 2.54171985 |
| 19 | MP0004510_myositis | 2.53521980 |
| 20 | MP0005257_abnormal_intraocular_pressure | 2.43179060 |
| 21 | MP0003191_abnormal_cellular_cholesterol | 2.40419404 |
| 22 | MP0002419_abnormal_innate_immunity | 2.38820239 |
| 23 | MP0003172_abnormal_lysosome_physiology | 2.35384890 |
| 24 | MP0003724_increased_susceptibility_to | 2.34752907 |
| 25 | MP0003566_abnormal_cell_adhesion | 2.28027144 |
| 26 | MP0006054_spinal_hemorrhage | 2.25838537 |
| 27 | MP0001835_abnormal_antigen_presentation | 2.24866842 |
| 28 | MP0003075_altered_response_to | 2.19182618 |
| 29 | MP0005387_immune_system_phenotype | 2.13682161 |
| 30 | MP0001790_abnormal_immune_system | 2.13682161 |
| 31 | MP0005451_abnormal_body_composition | 2.09546597 |
| 32 | MP0002060_abnormal_skin_morphology | 2.08575611 |
| 33 | MP0000604_amyloidosis | 2.07814181 |
| 34 | MP0005000_abnormal_immune_tolerance | 2.07512382 |
| 35 | MP0005508_abnormal_skeleton_morphology | 2.04742621 |
| 36 | MP0009764_decreased_sensitivity_to | 1.96976905 |
| 37 | MP0002295_abnormal_pulmonary_circulatio | 1.91512310 |
| 38 | MP0005025_abnormal_response_to | 1.89904919 |
| 39 | MP0005023_abnormal_wound_healing | 1.89072684 |
| 40 | MP0005671_abnormal_response_to | 1.85006785 |
| 41 | MP0001853_heart_inflammation | 1.84834637 |
| 42 | MP0003091_abnormal_cell_migration | 1.84396727 |
| 43 | MP0003385_abnormal_body_wall | 1.83057610 |
| 44 | MP0009278_abnormal_bone_marrow | 1.79385826 |
| 45 | MP0004947_skin_inflammation | 1.78162270 |
| 46 | MP0002139_abnormal_hepatobiliary_system | 1.77099545 |
| 47 | MP0002452_abnormal_antigen_presenting | 1.74740871 |
| 48 | MP0000685_abnormal_immune_system | 1.71773896 |
| 49 | MP0002254_reproductive_system_inflammat | 1.69537152 |
| 50 | MP0009250_abnormal_appendicular_skeleto | 1.68203118 |
| 51 | MP0010030_abnormal_orbit_morphology | 1.64192536 |
| 52 | MP0002723_abnormal_immune_serum | 1.52907000 |
| 53 | MP0009053_abnormal_anal_canal | 1.52350812 |
| 54 | MP0000858_altered_metastatic_potential | 1.51328226 |
| 55 | MP0001845_abnormal_inflammatory_respons | 1.50096045 |
| 56 | MP0002896_abnormal_bone_mineralization | 1.49574161 |
| 57 | MP0001299_abnormal_eye_distance/ | 1.46943153 |
| 58 | MP0005167_abnormal_blood-brain_barrier | 1.45883343 |
| 59 | MP0001542_abnormal_bone_strength | 1.44170184 |
| 60 | MP0008469_abnormal_protein_level | 1.43926294 |
| 61 | MP0001243_abnormal_dermal_layer | 1.43864566 |
| 62 | MP0000013_abnormal_adipose_tissue | 1.41796914 |
| 63 | MP0000767_abnormal_smooth_muscle | 1.41581298 |
| 64 | MP0002405_respiratory_system_inflammati | 1.41019850 |
| 65 | MP0000733_abnormal_muscle_development | 1.36524337 |
| 66 | MP0002282_abnormal_trachea_morphology | 1.36409467 |
| 67 | MP0001545_abnormal_hematopoietic_system | 1.35913953 |
| 68 | MP0005397_hematopoietic_system_phenotyp | 1.35913953 |
| 69 | MP0002877_abnormal_melanocyte_morpholog | 1.34063629 |
| 70 | MP0003806_abnormal_nucleotide_metabolis | 1.34005510 |
| 71 | MP0001800_abnormal_humoral_immune | 1.33620093 |
| 72 | MP0002108_abnormal_muscle_morphology | 1.32655307 |
| 73 | MP0003690_abnormal_glial_cell | 1.31438237 |
| 74 | MP0005310_abnormal_salivary_gland | 1.29356034 |
| 75 | MP0001819_abnormal_immune_cell | 1.26634713 |
| 76 | MP0002420_abnormal_adaptive_immunity | 1.26145711 |
| 77 | MP0008004_abnormal_stomach_pH | 1.26008078 |
| 78 | MP0002168_other_aberrant_phenotype | 1.25386101 |
| 79 | MP0010155_abnormal_intestine_physiology | 1.25070313 |
| 80 | MP0001348_abnormal_lacrimal_gland | 1.24882410 |
| 81 | MP0000534_abnormal_ureter_morphology | 1.23717553 |
| 82 | MP0003942_abnormal_urinary_system | 1.23061523 |
| 83 | MP0003656_abnormal_erythrocyte_physiolo | 1.22565368 |
| 84 | MP0005166_decreased_susceptibility_to | 1.22361916 |
| 85 | MP0010368_abnormal_lymphatic_system | 1.21058570 |
| 86 | MP0005464_abnormal_platelet_physiology | 1.20915422 |
| 87 | MP0005390_skeleton_phenotype | 1.20541950 |
| 88 | MP0002933_joint_inflammation | 1.19108096 |
| 89 | MP0002932_abnormal_joint_morphology | 1.18573151 |
| 90 | MP0003828_pulmonary_edema | 1.17114838 |
| 91 | MP0000163_abnormal_cartilage_morphology | 1.14866872 |
| 92 | MP0003283_abnormal_digestive_organ | 1.14790490 |
| 93 | MP0005367_renal/urinary_system_phenotyp | 1.13016795 |
| 94 | MP0000516_abnormal_urinary_system | 1.13016795 |
| 95 | MP0000428_abnormal_craniofacial_morphol | 1.12013337 |
| 96 | MP0003300_gastrointestinal_ulcer | 1.11177900 |
| 97 | MP0002115_abnormal_skeleton_extremities | 1.10124548 |
| 98 | MP0003115_abnormal_respiratory_system | 1.10033495 |
| 99 | MP0002332_abnormal_exercise_endurance | 1.08008822 |
| 100 | MP0005165_increased_susceptibility_to | 1.05966786 |
| 101 | MP0004233_abnormal_muscle_weight | 1.05757896 |
| 102 | MP0005076_abnormal_cell_differentiation | 1.05198122 |
| 103 | MP0004134_abnormal_chest_morphology | 1.03674403 |
| 104 | MP0003045_fibrosis | 1.03634688 |
| 105 | MP0003755_abnormal_palate_morphology | 1.01725460 |
| 106 | MP0000920_abnormal_myelination | 1.01594121 |
| 107 | MP0004883_abnormal_blood_vessel | 0.99864529 |
| 108 | MP0003941_abnormal_skin_development | 0.99788081 |
| 109 | MP0000003_abnormal_adipose_tissue | 0.98117661 |
| 110 | MP0002113_abnormal_skeleton_development | 0.97347524 |
| 111 | MP0009333_abnormal_splenocyte_physiolog | 0.96823701 |
| 112 | MP0000371_diluted_coat_color | 0.94794585 |
| 113 | MP0003329_amyloid_beta_deposits | 0.94477293 |
| 114 | MP0001879_abnormal_lymphatic_vessel | 0.92673441 |
| 115 | MP0002249_abnormal_larynx_morphology | 0.91559029 |
| 116 | MP0008260_abnormal_autophagy | 0.91528312 |
| 117 | MP0002233_abnormal_nose_morphology | 0.88273345 |
| 118 | MP0003950_abnormal_plasma_membrane | 0.87666766 |
| 119 | MP0000432_abnormal_head_morphology | 0.86529886 |
| 120 | MP0002128_abnormal_blood_circulation | 0.85647006 |
| 121 | MP0000537_abnormal_urethra_morphology | 0.84562365 |
| 122 | MP0005647_abnormal_sex_gland | 0.83077642 |
| 123 | MP0000716_abnormal_immune_system | 0.82631785 |
| 124 | MP0001533_abnormal_skeleton_physiology | 0.81879103 |
| 125 | MP0000049_abnormal_middle_ear | 0.81607333 |
| 126 | MP0001614_abnormal_blood_vessel | 0.81555011 |
| 127 | MP0003937_abnormal_limbs/digits/tail_de | 0.81217062 |
| 128 | MP0003935_abnormal_craniofacial_develop | 0.80829860 |
| 129 | MP0002998_abnormal_bone_remodeling | 0.80736841 |
| 130 | MP0002133_abnormal_respiratory_system | 0.80140023 |
| 131 | MP0005388_respiratory_system_phenotype | 0.80140023 |
| 132 | MP0001915_intracranial_hemorrhage | 0.79706457 |
| 133 | MP0010234_abnormal_vibrissa_follicle | 0.79518149 |
| 134 | MP0000762_abnormal_tongue_morphology | 0.79140971 |
| 135 | MP0009763_increased_sensitivity_to | 0.78385753 |
| 136 | MP0002697_abnormal_eye_size | 0.78369979 |
| 137 | MP0005164_abnormal_response_to | 0.74183223 |
| 138 | MP0004185_abnormal_adipocyte_glucose | 0.74020217 |
| 139 | MP0002111_abnormal_tail_morphology | 0.74018887 |
| 140 | MP0002116_abnormal_craniofacial_bone | 0.73979808 |
| 141 | MP0000249_abnormal_blood_vessel | 0.73785718 |
| 142 | MP0001346_abnormal_lacrimal_gland | 0.73213173 |
| 143 | MP0001849_ear_inflammation | 0.72747046 |
| 144 | MP0005595_abnormal_vascular_smooth | 0.71877421 |
| 145 | MP0002109_abnormal_limb_morphology | 0.71866161 |
| 146 | MP0001177_atelectasis | 0.70819111 |
| 147 | MP0003795_abnormal_bone_structure | 0.70463162 |
| 148 | MP0002234_abnormal_pharynx_morphology | 0.69981743 |
| 149 | MP0003453_abnormal_keratinocyte_physiol | 0.69549807 |
| 150 | MP0003448_altered_tumor_morphology | 0.68780181 |
| 151 | MP0002925_abnormal_cardiovascular_devel | 0.67763568 |
| 152 | MP0003634_abnormal_glial_cell | 0.67377566 |
| 153 | * MP0005197_abnormal_uvea_morphology | 0.67174920 |
| 154 | MP0009765_abnormal_xenobiotic_induced | 0.66919050 |
| 155 | MP0008875_abnormal_xenobiotic_pharmacok | 0.66390698 |
| 156 | * MP0005193_abnormal_anterior_eye | 0.66147919 |
| 157 | MP0004808_abnormal_hematopoietic_stem | 0.65842329 |
| 158 | MP0001727_abnormal_embryo_implantation | 0.65632834 |
| 159 | MP0009780_abnormal_chondrocyte_physiolo | 0.65532902 |
| 160 | MP0002177_abnormal_outer_ear | 0.64869959 |
| 161 | MP0010307_abnormal_tumor_latency | 0.64558493 |
| 162 | MP0010771_integument_phenotype | 0.64379178 |
| 163 | MP0002092_abnormal_eye_morphology | 0.64005497 |
| 164 | MP0002089_abnormal_postnatal_growth/wei | 0.63990133 |
| 165 | MP0001175_abnormal_lung_morphology | 0.63622880 |
| 166 | MP0005375_adipose_tissue_phenotype | 0.63356047 |
| 167 | MP0001851_eye_inflammation | 0.61854324 |
| 168 | * MP0008874_decreased_physiological_sensi | 0.61730160 |
| 169 | MP0006138_congestive_heart_failure | 0.61720391 |
| 170 | MP0005248_abnormal_Harderian_gland | 0.60755739 |
| 171 | MP0001340_abnormal_eyelid_morphology | 0.60297957 |
| 172 | MP0000750_abnormal_muscle_regeneration | 0.60194473 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Protrusio acetabuli (HP:0003179) | 8.67831151 |
| 2 | Premature rupture of membranes (HP:0001788) | 8.04577186 |
| 3 | Abnormality of liposaccharide metabolism (HP:0010968) | 7.64841484 |
| 4 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 7.64841484 |
| 5 | Abnormality of glycolipid metabolism (HP:0010969) | 7.64841484 |
| 6 | Vacuolated lymphocytes (HP:0001922) | 5.82438247 |
| 7 | Aortic dissection (HP:0002647) | 5.14798953 |
| 8 | Peritonitis (HP:0002586) | 5.01537180 |
| 9 | Ankle contracture (HP:0006466) | 4.97447840 |
| 10 | Shallow orbits (HP:0000586) | 4.96911397 |
| 11 | Dysostosis multiplex (HP:0000943) | 4.95680482 |
| 12 | Soft skin (HP:0000977) | 4.89446507 |
| 13 | Increased cerebral lipofuscin (HP:0011813) | 4.88391645 |
| 14 | Atrophic scars (HP:0001075) | 4.82651331 |
| 15 | Aortic aneurysm (HP:0004942) | 4.55361539 |
| 16 | Abnormality of macrophages (HP:0004311) | 4.53031451 |
| 17 | Bladder diverticulum (HP:0000015) | 4.48722326 |
| 18 | Loss of speech (HP:0002371) | 4.23022734 |
| 19 | Dilatation of the ascending aorta (HP:0005111) | 4.16854720 |
| 20 | Abnormality of dentin (HP:0010299) | 4.10099537 |
| 21 | Cerebral aneurysm (HP:0004944) | 4.08012843 |
| 22 | Systemic lupus erythematosus (HP:0002725) | 4.07983163 |
| 23 | Broad metatarsal (HP:0001783) | 4.03362288 |
| 24 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.94801698 |
| 25 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.94801698 |
| 26 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.94801698 |
| 27 | Disinhibition (HP:0000734) | 3.94575872 |
| 28 | Cervical subluxation (HP:0003308) | 3.91853572 |
| 29 | Follicular hyperkeratosis (HP:0007502) | 3.90241634 |
| 30 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.87336607 |
| 31 | Mucopolysacchariduria (HP:0008155) | 3.87336607 |
| 32 | Fragile skin (HP:0001030) | 3.85392883 |
| 33 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.84035109 |
| 34 | Genu recurvatum (HP:0002816) | 3.83039900 |
| 35 | Neonatal short-limb short stature (HP:0008921) | 3.77932316 |
| 36 | Wrist flexion contracture (HP:0001239) | 3.64015905 |
| 37 | Recurrent bacterial skin infections (HP:0005406) | 3.63536900 |
| 38 | Nuclear cataract (HP:0100018) | 3.62960195 |
| 39 | Recurrent abscess formation (HP:0002722) | 3.61437455 |
| 40 | Vascular tortuosity (HP:0004948) | 3.57950605 |
| 41 | Wormian bones (HP:0002645) | 3.53687668 |
| 42 | Mitral valve prolapse (HP:0001634) | 3.52784938 |
| 43 | Eczematoid dermatitis (HP:0000976) | 3.48901536 |
| 44 | Mutism (HP:0002300) | 3.46587324 |
| 45 | Neurofibrillary tangles (HP:0002185) | 3.40855992 |
| 46 | Biconcave vertebral bodies (HP:0004586) | 3.36890149 |
| 47 | Myocardial infarction (HP:0001658) | 3.34333455 |
| 48 | Vertebral compression fractures (HP:0002953) | 3.33190663 |
| 49 | Blue sclerae (HP:0000592) | 3.33115303 |
| 50 | Bowel diverticulosis (HP:0005222) | 3.29980205 |
| 51 | Spinal rigidity (HP:0003306) | 3.06770499 |
| 52 | Axonal loss (HP:0003447) | 3.06173739 |
| 53 | Arterial tortuosity (HP:0005116) | 3.03777385 |
| 54 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.00419955 |
| 55 | Type 1 muscle fiber predominance (HP:0003803) | 2.99952988 |
| 56 | Hyperextensible skin (HP:0000974) | 2.91267350 |
| 57 | Infantile muscular hypotonia (HP:0008947) | 2.88663582 |
| 58 | Autoimmune thrombocytopenia (HP:0001973) | 2.84803681 |
| 59 | Overgrowth (HP:0001548) | 2.82381599 |
| 60 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 2.77999197 |
| 61 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.73983667 |
| 62 | Elbow flexion contracture (HP:0002987) | 2.73690949 |
| 63 | Orchitis (HP:0100796) | 2.73329937 |
| 64 | Mediastinal lymphadenopathy (HP:0100721) | 2.70977745 |
| 65 | Abnormal delivery (HP:0001787) | 2.67659665 |
| 66 | Apathy (HP:0000741) | 2.65635263 |
| 67 | Aneurysm (HP:0002617) | 2.63483019 |
| 68 | Diminished motivation (HP:0000745) | 2.62635427 |
| 69 | Cerebral inclusion bodies (HP:0100314) | 2.60401888 |
| 70 | Glomerulonephritis (HP:0000099) | 2.56444507 |
| 71 | Deviation of the hallux (HP:0010051) | 2.52941847 |
| 72 | Retrobulbar optic neuritis (HP:0100654) | 2.51955856 |
| 73 | Optic neuritis (HP:0100653) | 2.51955856 |
| 74 | Abnormality of the acetabulum (HP:0003170) | 2.49739184 |
| 75 | Ectopia lentis (HP:0001083) | 2.49677770 |
| 76 | Hallux valgus (HP:0001822) | 2.48504334 |
| 77 | Increased connective tissue (HP:0009025) | 2.44692413 |
| 78 | Metaphyseal irregularity (HP:0003025) | 2.44384839 |
| 79 | Thin bony cortex (HP:0002753) | 2.43008307 |
| 80 | Slender build (HP:0001533) | 2.40044470 |
| 81 | Hematochezia (HP:0002573) | 2.39784217 |
| 82 | Neuronal loss in central nervous system (HP:0002529) | 2.39404876 |
| 83 | Asymmetric septal hypertrophy (HP:0001670) | 2.38032452 |
| 84 | Wide anterior fontanel (HP:0000260) | 2.37968103 |
| 85 | Abnormality of the peritoneum (HP:0002585) | 2.36432494 |
| 86 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.36099804 |
| 87 | Osteolytic defects of the hand bones (HP:0009699) | 2.36099804 |
| 88 | Myositis (HP:0100614) | 2.35939873 |
| 89 | Camptodactyly of toe (HP:0001836) | 2.35433985 |
| 90 | Increased serum ferritin (HP:0003281) | 2.34909079 |
| 91 | Increased variability in muscle fiber diameter (HP:0003557) | 2.34395099 |
| 92 | Tibial bowing (HP:0002982) | 2.33026453 |
| 93 | Progressive neurologic deterioration (HP:0002344) | 2.32123029 |
| 94 | Mitral regurgitation (HP:0001653) | 2.31528024 |
| 95 | Breech presentation (HP:0001623) | 2.28790874 |
| 96 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.27968747 |
| 97 | Joint laxity (HP:0001388) | 2.26800343 |
| 98 | Prolonged neonatal jaundice (HP:0006579) | 2.25534382 |
| 99 | Absent frontal sinuses (HP:0002688) | 2.25290356 |
| 100 | Hepatosplenomegaly (HP:0001433) | 2.21307238 |
| 101 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.21026121 |
| 102 | Bone pain (HP:0002653) | 2.19573786 |
| 103 | Broad ribs (HP:0000885) | 2.17613503 |
| 104 | Knee flexion contracture (HP:0006380) | 2.15456599 |
| 105 | Spinal cord lesions (HP:0100561) | 2.14927270 |
| 106 | Syringomyelia (HP:0003396) | 2.14927270 |
| 107 | Asymmetry of the thorax (HP:0001555) | 2.13682719 |
| 108 | Ulnar bowing (HP:0003031) | 2.13148373 |
| 109 | Increased density of long bones (HP:0006392) | 2.13058049 |
| 110 | Mesomelia (HP:0003027) | 2.12756099 |
| 111 | Cardiomegaly (HP:0001640) | 2.11698868 |
| 112 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.11219607 |
| 113 | Protuberant abdomen (HP:0001538) | 2.10663543 |
| 114 | Femoral bowing (HP:0002980) | 2.10455857 |
| 115 | Upper motor neuron abnormality (HP:0002127) | 2.08297488 |
| 116 | Coronal craniosynostosis (HP:0004440) | 2.05311550 |
| 117 | Purpura (HP:0000979) | 2.04798499 |
| 118 | Inappropriate behavior (HP:0000719) | 2.03680316 |
| 119 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.03376596 |
| 120 | Amyloidosis (HP:0011034) | 2.03279057 |
| 121 | Coxa vara (HP:0002812) | 2.02605941 |
| 122 | Short nail (HP:0001799) | 2.02177727 |
| 123 | Bell-shaped thorax (HP:0001591) | 2.02171046 |
| 124 | Venous abnormality (HP:0002624) | 2.01719401 |
| 125 | Ovoid vertebral bodies (HP:0003300) | 2.00281788 |
| 126 | Nonimmune hydrops fetalis (HP:0001790) | 1.98686128 |
| 127 | Pathologic fracture (HP:0002756) | 1.98203000 |
| 128 | Aortic regurgitation (HP:0001659) | 1.97927685 |
| 129 | Interstitial pulmonary disease (HP:0006530) | 1.97868985 |
| 130 | Spondylolisthesis (HP:0003302) | 1.97051169 |
| 131 | Pulmonary infiltrates (HP:0002113) | 1.96313576 |
| 132 | J-shaped sella turcica (HP:0002680) | 1.95189380 |
| 133 | Agnosia (HP:0010524) | 1.94848846 |
| 134 | Abnormality of the anterior chamber (HP:0000593) | 1.94011614 |
| 135 | Gingivitis (HP:0000230) | 1.93547091 |
| 136 | Osteoarthritis (HP:0002758) | 1.92993219 |
| 137 | Round ear (HP:0100830) | 1.92962633 |
| 138 | Esophageal varix (HP:0002040) | 1.92071151 |
| 139 | Hypoplasia of the iris (HP:0007676) | 1.91593067 |
| 140 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 1.91520032 |
| 141 | Stomatitis (HP:0010280) | 1.91375264 |
| 142 | Venous insufficiency (HP:0005293) | 1.91128499 |
| 143 | Recurrent skin infections (HP:0001581) | 1.90015363 |
| 144 | Broad long bones (HP:0005622) | 1.89908464 |
| 145 | Basal ganglia calcification (HP:0002135) | 1.89002122 |
| 146 | Complement deficiency (HP:0004431) | 1.87019492 |
| 147 | Dementia (HP:0000726) | 1.87009663 |
| 148 | Osteopenia (HP:0000938) | 1.86385510 |
| 149 | Abnormality of the periventricular white matter (HP:0002518) | 1.84866630 |
| 150 | Tetraparesis (HP:0002273) | 1.84668547 |
| 151 | Bowing of the arm (HP:0006488) | 1.83483282 |
| 152 | Bowed forearm bones (HP:0003956) | 1.83483282 |
| 153 | Decreased skull ossification (HP:0004331) | 1.82530935 |
| 154 | Microglossia (HP:0000171) | 1.82192558 |
| 155 | Inguinal hernia (HP:0000023) | 1.81101957 |
| 156 | Thoracic kyphosis (HP:0002942) | 1.81023654 |
| 157 | Upper limb amyotrophy (HP:0009129) | 1.80370775 |
| 158 | Distal upper limb amyotrophy (HP:0007149) | 1.80370775 |
| 159 | Joint stiffness (HP:0001387) | 1.80140242 |
| 160 | Spinal cord compression (HP:0002176) | 1.80013014 |
| 161 | Radial bowing (HP:0002986) | 1.79567290 |
| 162 | Abnormality of the calcaneus (HP:0008364) | 1.78986026 |
| 163 | Increased CSF protein (HP:0002922) | 1.78785157 |
| 164 | Short 4th metacarpal (HP:0010044) | 1.77803240 |
| 165 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 1.77803240 |
| 166 | Morphological abnormality of the middle ear (HP:0008609) | 1.75328223 |
| 167 | Flexion contracture of toe (HP:0005830) | 1.73914736 |
| 168 | Joint contractures involving the joints of the feet (HP:0100492) | 1.73914736 |
| 169 | Polyneuropathy (HP:0001271) | 1.73252243 |
| 170 | Tarsal synostosis (HP:0008368) | 1.72018674 |
| 171 | Scapular winging (HP:0003691) | 1.71565875 |
| 172 | Personality changes (HP:0000751) | 1.71131855 |
| 173 | Abnormality of complement system (HP:0005339) | 1.70010193 |
| 174 | Abnormality of skull ossification (HP:0002703) | 1.69976055 |
| 175 | Platyspondyly (HP:0000926) | 1.69934380 |
| 176 | Disproportionate tall stature (HP:0001519) | 1.69083830 |
| 177 | Protruding ear (HP:0000411) | 1.68940031 |
| 178 | Spontaneous hematomas (HP:0007420) | 1.68809867 |
| 179 | Peripheral demyelination (HP:0011096) | 1.68487098 |
| 180 | Abnormality of iron homeostasis (HP:0011031) | 1.67112039 |
| 181 | Chronic obstructive pulmonary disease (HP:0006510) | 1.66634333 |
| 182 | Obstructive lung disease (HP:0006536) | 1.66634333 |
| 183 | Flared iliac wings (HP:0002869) | 1.66184896 |
| 184 | Progressive visual loss (HP:0000529) | 1.64964156 |
| 185 | Hemoptysis (HP:0002105) | 1.64721564 |
| 186 | Acrocyanosis (HP:0001063) | 1.64170749 |
| 187 | Retinal atrophy (HP:0001105) | 1.62316417 |
| 188 | Petechiae (HP:0000967) | 1.61792793 |
| 189 | Abnormality of the frontal sinuses (HP:0002687) | 1.59988070 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRAK3 | 5.43165455 |
| 2 | DDR2 | 4.90727267 |
| 3 | TTN | 4.20093071 |
| 4 | TRIB3 | 3.70154561 |
| 5 | NME2 | 3.60800476 |
| 6 | PDGFRA | 3.57971475 |
| 7 | LATS1 | 3.25500967 |
| 8 | LATS2 | 2.95580327 |
| 9 | GRK7 | 2.88867330 |
| 10 | MAP3K14 | 2.87428007 |
| 11 | EPHB2 | 2.82319807 |
| 12 | PKN2 | 2.51146906 |
| 13 | SIK1 | 2.46242390 |
| 14 | ERN1 | 2.45395471 |
| 15 | TYK2 | 2.26982215 |
| 16 | PAK2 | 2.25349207 |
| 17 | TBK1 | 2.22311689 |
| 18 | BLK | 2.22157042 |
| 19 | MATK | 2.21811643 |
| 20 | TAOK2 | 2.21808104 |
| 21 | PRPF4B | 2.10580149 |
| 22 | PAK3 | 2.08986387 |
| 23 | FER | 2.00069504 |
| 24 | RIPK1 | 1.95823295 |
| 25 | PTK2 | 1.83785657 |
| 26 | RIPK4 | 1.76733967 |
| 27 | CSK | 1.76494089 |
| 28 | TRPM7 | 1.75988627 |
| 29 | FRK | 1.74989529 |
| 30 | EPHA3 | 1.74272586 |
| 31 | LRRK2 | 1.73340084 |
| 32 | FGR | 1.73161286 |
| 33 | IRAK4 | 1.66585272 |
| 34 | IKBKB | 1.60018349 |
| 35 | DMPK | 1.55490020 |
| 36 | PTK6 | 1.53913917 |
| 37 | BMX | 1.53211043 |
| 38 | MAP2K3 | 1.50077107 |
| 39 | TESK1 | 1.49781787 |
| 40 | STK3 | 1.46960526 |
| 41 | ACVR1B | 1.36179673 |
| 42 | PAK4 | 1.34122641 |
| 43 | NEK9 | 1.27244085 |
| 44 | IKBKE | 1.25626726 |
| 45 | PDGFRB | 1.25434134 |
| 46 | MAP3K11 | 1.23823245 |
| 47 | PIK3CA | 1.22814157 |
| 48 | FGFR1 | 1.19831697 |
| 49 | SCYL2 | 1.19367754 |
| 50 | BMPR2 | 1.19356915 |
| 51 | EPHA2 | 1.17106952 |
| 52 | ROCK1 | 1.15366424 |
| 53 | LIMK1 | 1.14700132 |
| 54 | PTK2B | 1.14570729 |
| 55 | RPS6KA4 | 1.14492311 |
| 56 | CSF1R | 1.14063920 |
| 57 | IRAK2 | 1.13535913 |
| 58 | TGFBR2 | 1.13147052 |
| 59 | CAMK1G | 1.11891258 |
| 60 | CHUK | 1.11542570 |
| 61 | MAP3K13 | 1.10139699 |
| 62 | EEF2K | 1.07827681 |
| 63 | MET | 1.07673875 |
| 64 | CAMK1D | 1.05641359 |
| 65 | ZAP70 | 1.05051474 |
| 66 | EPHB1 | 1.04237653 |
| 67 | FGFR2 | 1.03129011 |
| 68 | PIM2 | 1.02635371 |
| 69 | MTOR | 1.02290546 |
| 70 | NTRK1 | 1.01057109 |
| 71 | MOS | 0.99535221 |
| 72 | CDK6 | 0.96676499 |
| 73 | MAP2K1 | 0.93338234 |
| 74 | PLK2 | 0.86114243 |
| 75 | ERBB3 | 0.85400860 |
| 76 | MAP3K1 | 0.84740606 |
| 77 | ROCK2 | 0.83687153 |
| 78 | MYLK | 0.80985294 |
| 79 | ADRBK2 | 0.79297219 |
| 80 | PIK3CG | 0.78544572 |
| 81 | SIK3 | 0.75143642 |
| 82 | FGFR3 | 0.74941024 |
| 83 | RET | 0.74206448 |
| 84 | ILK | 0.73766507 |
| 85 | INSR | 0.71999958 |
| 86 | DYRK1B | 0.71231393 |
| 87 | STK10 | 0.71207907 |
| 88 | JAK1 | 0.68951400 |
| 89 | FLT3 | 0.68909051 |
| 90 | JAK2 | 0.68361692 |
| 91 | ICK | 0.67616150 |
| 92 | DAPK3 | 0.67608321 |
| 93 | IRAK1 | 0.66456894 |
| 94 | MAP3K5 | 0.60951507 |
| 95 | PRKD1 | 0.59213089 |
| 96 | FGFR4 | 0.58415785 |
| 97 | ABL2 | 0.57013060 |
| 98 | MARK3 | 0.56117110 |
| 99 | RPS6KC1 | 0.55447898 |
| 100 | RPS6KL1 | 0.55447898 |
| 101 | TYRO3 | 0.54024740 |
| 102 | KIT | 0.53417831 |
| 103 | PDPK1 | 0.52829643 |
| 104 | LYN | 0.52271405 |
| 105 | MAP4K1 | 0.51402252 |
| 106 | CLK1 | 0.51124297 |
| 107 | SRC | 0.50119876 |
| 108 | LMTK2 | 0.50114361 |
| 109 | PAK1 | 0.48300706 |
| 110 | ADRBK1 | 0.48178279 |
| 111 | CDC42BPA | 0.48063208 |
| 112 | STK38L | 0.47213664 |
| 113 | ARAF | 0.46979322 |
| 114 | HCK | 0.46583606 |
| 115 | MELK | 0.46385057 |
| 116 | TESK2 | 0.45868711 |
| 117 | NUAK1 | 0.45508441 |
| 118 | TGFBR1 | 0.45219392 |
| 119 | PRKCH | 0.45187872 |
| 120 | PRKD2 | 0.44474150 |
| 121 | MAP3K2 | 0.43741165 |
| 122 | MAP3K8 | 0.42749658 |
| 123 | PAK6 | 0.41444735 |
| 124 | KSR2 | 0.41442761 |
| 125 | MAPK4 | 0.40797123 |
| 126 | PDK2 | 0.40272607 |
| 127 | MAP3K10 | 0.40082944 |
| 128 | MAP3K3 | 0.39366840 |
| 129 | MAPK7 | 0.39359028 |
| 130 | TAOK1 | 0.38467292 |
| 131 | ERBB4 | 0.38425378 |
| 132 | PDK3 | 0.37978394 |
| 133 | PDK4 | 0.37978394 |
| 134 | RPS6KA6 | 0.37830232 |
| 135 | MAP3K12 | 0.36785897 |
| 136 | WNK1 | 0.35998197 |
| 137 | MAPKAPK3 | 0.35700568 |
| 138 | NEK6 | 0.34987169 |
| 139 | LCK | 0.34912898 |
| 140 | ABL1 | 0.34382786 |
| 141 | CAMKK1 | 0.34184929 |
| 142 | MAPKAPK2 | 0.34004303 |
| 143 | SMG1 | 0.32726047 |
| 144 | IGF1R | 0.32495102 |
| 145 | PRKG2 | 0.32440141 |
| 146 | ALK | 0.32061717 |
| 147 | CDK14 | 0.32050678 |
| 148 | MAP3K6 | 0.30092232 |
| 149 | MST1R | 0.29969781 |
| 150 | MAP2K6 | 0.29869591 |
| 151 | PDK1 | 0.29610405 |
| 152 | ERBB2 | 0.29069836 |
| 153 | RPS6KA2 | 0.28961013 |
| 154 | CAMKK2 | 0.26353347 |
| 155 | JAK3 | 0.26255819 |
| 156 | PRKCE | 0.25327506 |
| 157 | MAPK1 | 0.25276985 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ECM-receptor interaction_Homo sapiens_hsa04512 | 4.30271201 |
| 2 | Other glycan degradation_Homo sapiens_hsa00511 | 3.81568953 |
| 3 | Focal adhesion_Homo sapiens_hsa04510 | 3.17453277 |
| 4 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.66616103 |
| 5 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.61387119 |
| 6 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 2.57887085 |
| 7 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.56403488 |
| 8 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 2.54854694 |
| 9 | Adherens junction_Homo sapiens_hsa04520 | 2.47850408 |
| 10 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 2.42862827 |
| 11 | Protein digestion and absorption_Homo sapiens_hsa04974 | 2.39660105 |
| 12 | Bladder cancer_Homo sapiens_hsa05219 | 2.39246504 |
| 13 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.37171320 |
| 14 | Amoebiasis_Homo sapiens_hsa05146 | 2.33615583 |
| 15 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 2.24608755 |
| 16 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 2.22451493 |
| 17 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.12969611 |
| 18 | Tuberculosis_Homo sapiens_hsa05152 | 2.09182970 |
| 19 | Small cell lung cancer_Homo sapiens_hsa05222 | 2.04829291 |
| 20 | Hippo signaling pathway_Homo sapiens_hsa04390 | 2.03970027 |
| 21 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.96835651 |
| 22 | Malaria_Homo sapiens_hsa05144 | 1.95930354 |
| 23 | Pertussis_Homo sapiens_hsa05133 | 1.95564507 |
| 24 | Legionellosis_Homo sapiens_hsa05134 | 1.92697723 |
| 25 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.82600176 |
| 26 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.78031930 |
| 27 | Allograft rejection_Homo sapiens_hsa05330 | 1.75566876 |
| 28 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.74839106 |
| 29 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.74754479 |
| 30 | Asthma_Homo sapiens_hsa05310 | 1.74714445 |
| 31 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.72031630 |
| 32 | * MicroRNAs in cancer_Homo sapiens_hsa05206 | 1.71744448 |
| 33 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.67211741 |
| 34 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.64935589 |
| 35 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.60268796 |
| 36 | Basal cell carcinoma_Homo sapiens_hsa05217 | 1.60217197 |
| 37 | Melanoma_Homo sapiens_hsa05218 | 1.58534028 |
| 38 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.57607653 |
| 39 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.57121153 |
| 40 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 1.56998611 |
| 41 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.51898759 |
| 42 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.46902539 |
| 43 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 1.46003254 |
| 44 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.44894698 |
| 45 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.41051851 |
| 46 | Influenza A_Homo sapiens_hsa05164 | 1.39602101 |
| 47 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 1.38366855 |
| 48 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.34011051 |
| 49 | Glioma_Homo sapiens_hsa05214 | 1.32870534 |
| 50 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.30466602 |
| 51 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.30396384 |
| 52 | Tight junction_Homo sapiens_hsa04530 | 1.27455201 |
| 53 | Shigellosis_Homo sapiens_hsa05131 | 1.27449826 |
| 54 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.26446154 |
| 55 | Prion diseases_Homo sapiens_hsa05020 | 1.21724696 |
| 56 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.18317986 |
| 57 | Prostate cancer_Homo sapiens_hsa05215 | 1.17256051 |
| 58 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.15792081 |
| 59 | Hepatitis C_Homo sapiens_hsa05160 | 1.14780434 |
| 60 | Pathways in cancer_Homo sapiens_hsa05200 | 1.14676335 |
| 61 | Viral myocarditis_Homo sapiens_hsa05416 | 1.13204668 |
| 62 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 1.13166295 |
| 63 | Platelet activation_Homo sapiens_hsa04611 | 1.11149502 |
| 64 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.11060400 |
| 65 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.10263259 |
| 66 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.10017131 |
| 67 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.08630025 |
| 68 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.08359129 |
| 69 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.05182400 |
| 70 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 1.03741620 |
| 71 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.03162152 |
| 72 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.00607339 |
| 73 | Measles_Homo sapiens_hsa05162 | 0.99889381 |
| 74 | Axon guidance_Homo sapiens_hsa04360 | 0.99451735 |
| 75 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.96321126 |
| 76 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.94186610 |
| 77 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.93684881 |
| 78 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.92613364 |
| 79 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.90760923 |
| 80 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.90675156 |
| 81 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.90153326 |
| 82 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.89980260 |
| 83 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.89730080 |
| 84 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.89104996 |
| 85 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.88374113 |
| 86 | HTLV-I infection_Homo sapiens_hsa05166 | 0.85677861 |
| 87 | Mineral absorption_Homo sapiens_hsa04978 | 0.84926712 |
| 88 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.84260959 |
| 89 | Endometrial cancer_Homo sapiens_hsa05213 | 0.83563812 |
| 90 | Colorectal cancer_Homo sapiens_hsa05210 | 0.80072906 |
| 91 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.79869645 |
| 92 | Phagosome_Homo sapiens_hsa04145 | 0.79809936 |
| 93 | Melanogenesis_Homo sapiens_hsa04916 | 0.76912257 |
| 94 | Salmonella infection_Homo sapiens_hsa05132 | 0.72393402 |
| 95 | Thyroid cancer_Homo sapiens_hsa05216 | 0.71646012 |
| 96 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.69855179 |
| 97 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.69176269 |
| 98 | Galactose metabolism_Homo sapiens_hsa00052 | 0.67594836 |
| 99 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.67215918 |
| 100 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.66513958 |
| 101 | Hepatitis B_Homo sapiens_hsa05161 | 0.66395922 |
| 102 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.65509964 |
| 103 | Endocytosis_Homo sapiens_hsa04144 | 0.62645968 |
| 104 | Gap junction_Homo sapiens_hsa04540 | 0.60905461 |
| 105 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.59923423 |
| 106 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.59108859 |
| 107 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.58763131 |
| 108 | * Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.57903628 |
| 109 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.57773849 |
| 110 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.57138263 |
| 111 | Apoptosis_Homo sapiens_hsa04210 | 0.56493223 |
| 112 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.55952201 |
| 113 | Lysosome_Homo sapiens_hsa04142 | 0.54471463 |
| 114 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.53696781 |
| 115 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.53617695 |
| 116 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.53249265 |
| 117 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.52554727 |
| 118 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.52194146 |
| 119 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.49796586 |
| 120 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.49736495 |
| 121 | Insulin resistance_Homo sapiens_hsa04931 | 0.49446567 |
| 122 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.49188605 |
| 123 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.48874384 |
| 124 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.48311164 |
| 125 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.47351379 |
| 126 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.47149706 |
| 127 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.47065925 |
| 128 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.46292213 |
| 129 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.43502951 |
| 130 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.43413070 |
| 131 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.42252446 |
| 132 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.41866716 |
| 133 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.41012518 |
| 134 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.39682304 |
| 135 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.38980562 |
| 136 | Leishmaniasis_Homo sapiens_hsa05140 | 0.37787580 |
| 137 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.36836409 |
| 138 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.36495663 |
| 139 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.35541951 |
| 140 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.35437761 |
| 141 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.35215845 |
| 142 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.34789597 |
| 143 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.34366032 |
| 144 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.33893208 |
| 145 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.33556777 |
| 146 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.32196670 |
| 147 | Lysine degradation_Homo sapiens_hsa00310 | 0.32150642 |
| 148 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.32140927 |
| 149 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.31578496 |
| 150 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.31489247 |
| 151 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.31156799 |
| 152 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.30258130 |
| 153 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.29770828 |

